行情

THMO

THMO

热动力医疗
NASDAQ

实时行情|Nasdaq Last Sale

1.510
+0.250
+19.84%
盘后: 1.450 -0.06 -3.97% 16:59 11/26 EST
开盘
1.200
昨收
1.260
最高
1.890
最低
1.200
成交量
494.69万
成交额
--
52周最高
4.450
52周最低
1.200
市值
1,798.68万
市盈率(TTM)
-1.3725
分时
5日
1月
3月
1年
5年
回顾:ThermoGenesis Holdings 第三季度收益
ThermoGenesis Holdings (NASDAQ:THMO) reported its Q3 earnings results on Friday, November 12, 2021 at 04:00 PM. Here's what investors need to know about the announcement.
Benzinga · 11/15 22:21
BRIEF-Thermogenesis Holdings Announces Financial Results For The Third Quarter Ended September 30, 2021, And Provides Corporate Update
reuters.com · 11/12 21:13
ThermoGenesis EPS misses by $0.07, beats on revenue
ThermoGenesis (NASDAQ:THMO): Q3 GAAP EPS of -$0.15 misses by $0.07. Revenue of $3.16M (+33.9% Y/Y) beats by $0.1M. Press Release At September 30, 2021, the Company had cash and cash
Seekingalpha · 11/12 21:08
ThermoGenesis Q3 Loss Narrows as Revenue Climbs
MT Newswires · 11/12 16:25
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
Here's a roundup of top developments in the biotech space over the last 24 hours.
Benzinga · 11/12 12:40
Notable earnings after Friday's close
THMO For Seeking Alpha's full earnings season calendar, click here.
Seekingalpha · 11/11 22:35
ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2021 and Provide a Corporate Strategic Update
ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the third quarter ended September 30, 2...
PR Newswire · 11/05 12:30
ThermoGenesis Holdings 的资本使用回报率概览
ThermoGenesis Holdings (NASDAQ:THMO) brought in sales totaling $2.20 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 88.7%, resulting in a loss of $3.14 million.
Benzinga · 09/30 15:22
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解THMO最新的财务预测,通过THMO每股收益,每股净资产,每股现金流等数据分析热动力医疗近期的经营情况,然后做出明智的投资选择。
分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

0.00%强力推荐
100.00%买入
0.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测THMO价格均价为6.00,最高价位6.00,最低价为6.00。
最高6.00
均价6.00
最低6.00
现价1.510
EPS
实际EPS
预期EPS
-0.30-0.23-0.15-0.08
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
机构持股
总机构数: 24
机构持股: 43.77万
持股比例: 3.67%
总股本: 1,191.18万
类型机构数股数
增持
4
2.20万
建仓
3
1.42万
减持
2
27
平仓
5
6.64万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
办公设备
-1.69%
科技设备
-3.93%
高管信息
Chairman/President/Chief Executive Officer/Director
Xiaochun Xu
Chief Financial Officer
Jeffery Cauble
Independent Director
Debra Donaghy
Independent Director
Russell Medford
Independent Director
Joseph Thomis
暂无数据
THMO 简况
ThermoGenesis Holdings, Inc.(原名:Cesca Therapeutics Inc.)开发、商业化和销售一系列用于嵌合抗原受体(CAR)-T和其他细胞疗法的自动化技术。该公司提供了一系列用于自动化临床生物库、即时护理应用程序以及免疫肿瘤学自动化的解决方案。其CAR-TXpress平台是一种细胞调控平台。该公司在全球细胞和基因疗法市场中提供细胞生产工具和服务。

微牛提供Thermogenesis Holdings Inc(NASDAQ-THMO)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的THMO股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易THMO股票基本功能。